PLoS ONE (Jan 2024)
Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0278460.].
PLoS ONE (Jan 2024)
[This corrects the article DOI: 10.1371/journal.pone.0278460.].